Sofinnova Partners
Rafaèle Tordjman has been promoted to partner at Sofinnova Partners. She joined the group’s life science team as a research analyst in November 2001. Two years later she became an investment manager. Tordjman is a board member of portfolio companies Endotis Pharma and Endoart, as well as an observer at CoreValve. Prior to joining Sofinnova Partners, she was a research scientist at the Institut National de la Recherche Médicale (INSERM). Previously, Tordjman was a medical doctor specialising in clinical haematology and internal medicine. Her appointment brings the group’s total partnership to eight individuals, including managing partner, Jean-Bernard Schmidt.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








